SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.86−0.17 (-2.12%)
Close on Nov 13, 2026Market cap $1.59BP/E –Yield –
SELLAS Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
SELLAS Life Sciences's total debt was $0 at Dec 31, 2018. For fiscal 2018 it was $0, down 100.0% from the year before. The highest annual figure on record is $16.40M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $10.99M | -33.0% |
| FY2016 | Dec 31, 2016 | $16.40M | +246.0% |
| FY2015 | Dec 31, 2015 | $4.74M | -43.6% |
| FY2014 | Dec 31, 2014 | $8.40M | -15.1% |
| FY2013 | Dec 31, 2013 | $9.89M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $76.00K | -99.4% |
| Q2 FY2018 | Jun 30, 2018 | $7.78M | -40.3% |
| Q1 FY2018 | Mar 31, 2018 | $9.68M | -23.2% |
| Q4 FY2017 | Dec 31, 2017 | $10.99M | -33.0% |
| Q3 FY2017 | Sep 30, 2017 | $12.17M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.40M | – |
See a number that looks wrong?